Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a minor software revision to the page. No content or user-facing features appear to be altered.SummaryDifference0.0%

- Check18 days agoChange DetectedThe study's identifiers now include a line for '2018 ( U.S. NIH Grant/Contract )', indicating NIH funding for the trial.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a small internal update to the platform's rendering system.SummaryDifference0.0%

- Check39 days agoChange DetectedInvestigator Inquiry Form was removed from the study page. This eliminates a direct contact option for investigators to inquire about participation or obtain study details through the page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, reflecting a new deployment. It does not change the displayed information on the page.SummaryDifference0.0%

- Check75 days agoChange DetectedA new revision tag appears: Revision: v3.6.3, replacing the previous v3.6.0, indicating an update to the page version.SummaryDifference0.0%

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.